EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

H3K4me3 remodeling induced acquired resistance through O-GlcNAc transferase

Dinoop Ravindran Menon, Heinz Hammerlindl, Gregory Gimenez, Sabrina Hammerlindl, Elmar Zuegner, Joachim Torrano, Natalie Bordag, Abdullah Al Emran, Maybelline Giam, Simon Denil, Norman Pavelka, Aik-Choon Tan und 8 weitere

Drug Resistance Updates · 2023-11 · 71 · 100993

DOI: 10.1016/j.drup.2023.100993 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Resistance Updates, 2023-11. Verfasst von Dinoop Ravindran Menon und 19 weiteren Autor:innen. Beteiligte Einrichtung: Frazer Institute, The University of Queensland, Brisbane, QLD, Australia; Department of Dermatology, University of Colorado Denver, Aurora, CO, USA; …. Hauptthemen laut MEDLINE: Histones, AMP-Activated Protein Kinases. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: BLRD VA, NCI NIH HHS, VA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HistonesAMP-Activated Protein KinasesHumansDown-RegulationMixed Function OxygenasesProto-Oncogene ProteinsN-Acetylglucosaminyltransferases

Stichwörter der Autor:innen

Acquired drug resistanceAdaptive cancer drug resistanceCancer persistersCellular reprogrammingEpigeneticsH3K4me3MetabolismOGTTET1

Substanzen

HistonesAMP-Activated Protein KinasesMixed Function OxygenasesProto-Oncogene Proteinshistone H3 trimethyl Lys4O-GlcNAc transferaseN-AcetylglucosaminyltransferasesTET1 protein, human

Autor:innen und Institutionen

  • Frazer Institute, The University of Queensland, Brisbane, QLD, Australia; Department of Dermatology, University of Colorado Denver, Aurora, CO, USA; Department of Medical Oncology, University of Colorado Denver, Aurora,…
  • Frazer Institute, The University of Queensland, Brisbane, QLD, Australia; Department of Pharmaceutical Chemistry, The University of California, San Francisco, San Francisco, CA, USA.
  • Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.
  • Joanneum Research Forschungsgesellschaft m.b.H., HEALTH, Institute for Biomedicine and Health Sciences, Graz, Austria.
  • Frazer Institute, The University of Queensland, Brisbane, QLD, Australia.
  • Institute of Medical Biology, Agency for Science, Technology and Research, Immunos Singapore, Singapore.

Förderung

  • BLRD VA
  • NCI NIH HHS
  • VA

Zitieren

APA

Ravindran Menon, D., Hammerlindl, H., Gimenez, G., Hammerlindl, S., Zuegner, E., Torrano, J., Bordag, N., Emran, A. A., Giam, M., Denil, S., Pavelka, N., Tan, A. C., Sturm, R. A., Haass, N. K., Rancati, G., Herlyn, M., Magnes, C., Eccles, M. R., Fujita, M., & Schaider, H. (2023). H3K4me3 remodeling induced acquired resistance through O-GlcNAc transferase. Drug Resistance Updates, 71, 100993. https://doi.org/10.1016/j.drup.2023.100993

Vancouver

Ravindran Menon D, Hammerlindl H, Gimenez G, Hammerlindl S, Zuegner E, Torrano J, et al. H3K4me3 remodeling induced acquired resistance through O-GlcNAc transferase. Drug Resistance Updates. 2023;71:100993. doi:10.1016/j.drup.2023.100993

BibTeX
@article{RavindranMenon2023,
  author = {Ravindran Menon, Dinoop and Hammerlindl, Heinz and Gimenez, Gregory and Hammerlindl, Sabrina and Zuegner, Elmar and Torrano, Joachim and Bordag, Natalie and Emran, Abdullah Al and Giam, Maybelline and Denil, Simon and Pavelka, Norman and Tan, Aik-Choon and Sturm, Richard A and Haass, Nikolas K and Rancati, Giulia and Herlyn, Meenhard and Magnes, Christoph and Eccles, Michael R and Fujita, Mayumi and Schaider, Helmut},
  title = {H3K4me3 remodeling induced acquired resistance through O-GlcNAc transferase},
  journal = {Drug Resistance Updates},
  year = {2023},
  volume = {71},
  pages = {100993},
  doi = {10.1016/j.drup.2023.100993}
}
Kostenlos starten →